If a mutation is in the splice site (donor), how can we bioinformatically predict its function in silico? For example if the site is broken or not, is there any exon skipping, if no then how to find the next splice site?

Many mutations of the splice site have been published, for

example, IVS1þ1G>A, IVS3þ5_6GA>AC, and IVS5-1G>C

in EVC, and IVS4þ2T>C in EVC2. Tompson et al. [2007]

also reported mutation in EVC (IVS13þ5G>T) produced three alternative splicing in affected individuals.

How can we defend this mutation without expression studies, which is very difficult in Pakistan.

Similar questions and discussions